Antidepressant Therapy for the Geriatric Patient
Lissy F. Jarvik
Abstract
Lissy F. Jarvik
Abstract
Tricyclic antidepressants followed by the monoamine oxidase inhibitors are the mainstays of pharmacological antidepressant treatment for the elderly in the United States. Lithium is useful in selected patients. The newer agents, such as mianserin, nomifensine, trazodone, maprotiline, and amoxapine, appear to be effective and, if the early data are confirmed, may produce fewer side effects than the current tricyclics and monoamine oxidase inhibitors.
OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Tricyclic antidepressants followed by the monoamine oxidase inhibitors are the mainstays of pharmacological antidepressant treatment for the elderly in the United States. Lithium is useful in selected patients. The newer agents, such as mianserin, nomifensine, trazodone, maprotiline, and amoxapine, appear to be effective and, if the early data are confirmed, may produce fewer side effects than the current tricyclics and monoamine oxidase inhibitors.
Key concepts: Maprotiline, Mianserin, Nomifensine, Trazodone, Tricyclic, Antidepressant, Monoamine oxidase, Medicine